William Ershler, MD
Hematology & Oncology · Fairfax, VANPI 1669496881
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $110,917 of the $139,428 with a category attached, or 79.6%. 7 manufacturers reported payments, led by Global Blood Therapeutics, Inc. at 56.4% of the total. Reporting peaked in 2022 at $41,965 and has fallen 96.7% since, to $1,371 in 2025. Among hematology & oncology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $1032.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$79K
- Pfizer$38K
- Pharmacosmos Therapeutics Inc.$20K
- Novartis$3K
- Terumo BCT, Inc.$114
- Rigel Pharmaceuticals, Inc.$110
- plus $107 from 1 others
Across 40 payments — averaging $8645.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$305K
- Global Blood Therapeutics, Inc.$41K
- Incyte Corporation$278
What the payments were for
- Consulting fees$14,04810%
- Speaking & faculty fees$110,91780%
- Travel & lodging$7,1485%
- Food & beverage$7,3155%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 60 | $78,583 |
| Pfizer | 34 | $37,945 |
| Pharmacosmos Therapeutics Inc. | 32 | $19,979 |
| Novartis | 6 | $2,592 |
| Terumo BCT, Inc. | 1 | $114 |
| Rigel Pharmaceuticals, Inc. | 1 | $110 |
| Sobi, Inc | 1 | $107 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXBRYTA$96,943
- Monoferric$19,673
- VYNDAMAX$4,400
- ADAKVEO$2,468
- Spectra Optia$114
- Tavalisse$110
- DOPTELET$107
How this compares
$139,428 in reported general payments places this provider in the 95th percentile of 293 hematology & oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PromactaEltrombopag Olamine | 18 | $236,254 |
| EliquisApixaban | 17 | $23,844 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisPromacta | $2,592 | $236,25418 claims |
| PfizerEliquis | $37,945 | $23,84417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 293 hematology & oncology providers in Virginia.
Other hematology & oncology in Fairfax
- Sekwon JangFairfax$56K
- Raymond WadlowFairfax$30K
- Daniel ChongFairfax$15K
- Mohamad SalkeniFairfax$12K
- Ruby KochharHampton$236K
- Victor YazbeckRichmond$190K
- David ChangNewport News$141K
- Yue ZhangVirginia Beach$105K
- Jerome GoldschmidtChristiansburg$105K
- Attique SamdaniRichmond$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.